75F40126C00065↗

Name: 75F40126C00065: Eo 14398 Baa Identification and Performance Assessment of Medical Devices in Electronic Health Record Data Development of a Transparent and Repeatable Framework to Enhance Medical Device Integration in Real World Evidence Generation
Creator: SpendQuery
License: https://www.usa.gov/government-works

Rutgers the State University of New Jersey received this contract from Fda Office of Acq Grant Svcs, Food and Drug Administration: $6.52M obligated so far for health r&d services; health care services; applied research. It runs to 2027-09-14, or to 2031-09-14 if every option is exercised.

Key facts · data as of Oct 23, 2026

Recipient: Rutgers the State University of New Jersey
Awarding agency: Food and Drug Administration (Department of Health and Human Services)
Contracting office: Fda Office of Acq Grant Svcs (75F401)
Obligated to date: $6.52M
Potential value: $35.19M
Ends: 2027-09-14

Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 23, 2026.

Cite this page: SpendQuery, Award 75F40126C00065, data as of Oct 23, 2026, https://spendquery.com/award?id=CONT_AWD_75F40126C00065_7524_-NONE-_-NONE-

Rutgers the State University of New Jersey: all federal awards · Department of Health and Human Services: spending · Fda Office of Acq Grant Svcs: what it buys · The follow-on: recompete brief

EO 14398 BAA IDENTIFICATION AND PERFORMANCE ASSESSMENT OF MEDICAL DEVICES IN ELECTRONIC HEALTH RECORD DATA DEVELOPMENT OF A TRANSPARENT AND REPEATABLE FRAMEWORK TO ENHANCE MEDICAL DEVICE INTEGRATION IN REAL WORLD EVIDENCE GENERATION

Definitive Contract · Food and Drug Administration · to Rutgers the State University of New Jersey (UEI YVVTQD8CJC79) · data as of 2026-10-23

Obligated to date$6.52M2 actions

Current value$6.52Mwith options exercised

Potential value$35.19Mif every option is used

Period2026-09-15 → 2027-09-14up to 2031-09-14 with options

Up for re-bid: ends 2027-09-14. Recompete brief →

What it is

Product or service: Health R&D Services; Health Care Services; Applied Research (PSC AN12)
Industry: Research and Development in Biotechnology (Except Nanobiotechnology) (NAICS 541714)
Contracting office: Fda Office of Acq Grant Svcs (75F401)
Competition: Full and open competition · 257 offers received
Pricing: Firm fixed price
How it was bought: Standalone contract
Solicitation: FDABAA-26-00123
Where the work is: Middlesex, NJ · district NJ-06

Obligations by fiscal year

FY2026$6.52M

SpendQuery holds FY2023 on; earlier years are on USAspending.gov.

Subcontractors: where the money went next

No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.

Every action

2 actions since 2026-09-24. Each is a modification or amendment with the money it added or took back.

Date	Modification	Kind	Amount	What the agency wrote
2026-09-24	P00001	Administrative change	$0	EO 14398 BAA IDENTIFICATION AND PERFORMANCE ASSESSMENT OF MEDICAL DEVICES IN ELECTRONIC HEALTH RECORD DATA DEVELOPMENT OF A TRANSPARENT AND REPEATABLE FRAMEWORK TO ENHANCE MEDICAL DEVICE INTEGRATION IN REAL WORLD EVIDENCE GENERATION
2026-09-24	0		$6.52M	EO 14398 BAA IDENTIFICATION AND PERFORMANCE ASSESSMENT OF MEDICAL DEVICES IN ELECTRONIC HEALTH RECORD DATA DEVELOPMENT OF A TRANSPARENT AND REPEATABLE FRAMEWORK TO ENHANCE MEDICAL DEVICE INTEGRATION IN REAL WORLD EVIDENCE GENERATION

Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-23). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗

Putting the award page together from the records…